期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
新型液相色谱-荧光检测法测定药物剂型和人血浆中的他达拉非和盐酸达泊西汀(英文) 被引量:2
1
作者 maha hegazy AMIRA Kessiba +1 位作者 MOHAMED Abdelkawy AHMED EMAD El Gindy 《色谱》 CAS CSCD 北大核心 2015年第7期765-770,共6页
Tadalafil(TAD)and dapoxetine HCl(DAP)are recently co-formulated and both show native fluorescence.Therefore,a novel,accurate,specific and sensitive reversed-phase high performance liquid chromatographic method with fl... Tadalafil(TAD)and dapoxetine HCl(DAP)are recently co-formulated and both show native fluorescence.Therefore,a novel,accurate,specific and sensitive reversed-phase high performance liquid chromatographic method with fluorescence detection was developed and validated for their separation and quantitation in dosage form and human plasma using avanafil as an internal standard(IS).Separation was achieved using isocratic elution within 7.0 min on C18column and acetonitrile-0.15%triethylamine(40∶60,v/v;pH 4)as a mobile phase.The flow rate was 1.0 mL/min and the detection was time-programmed at 330,410 and 370 nm for TAD,DAP and IS,respectively,after excitation at 236 nm.The linear ranges from 0.01 to 30.00μg/mL for each drug with the limits of detection of 4.20 and 7.20 ng/mL for TAD and DAP,respectively.The method was validated in accordance to the International Conference on Harmonization(ICH)guidelines and was successfully applied to spiked human plasma with mean recoveries of 98.17%and 98.83%for TAD and DAP respectively. 展开更多
关键词 high performance liquid chromatography(HPLC) fluorescence detection tadalafil(TAD) dapoxetine HCl(DAP) dosage form human plasma
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部